Early transient radiation-induced brachial plexopathy in locally advanced head and neck cancer

Metcalfe E., ETİZ D.

Wspolczesna Onkologia, vol.20, no.1, pp.67-72, 2016 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.5114/wo.2015.55876
  • Journal Name: Wspolczesna Onkologia
  • Journal Indexes: Scopus
  • Page Numbers: pp.67-72
  • Keywords: Brachial plexus, Early transient radiation-induced brachial plexopathy (RIBP), Head and neck cancer, Radiotherapy
  • Istanbul Medipol University Affiliated: No


Aim of the study: Early transient brachial plexopathy following radiotherapy (RT) in patients with head and neck cancer may be underreported and associated with a dose-response. Our purpose was to determine the incidence of early transient radiation-nduced brachial plexopathy (RIBP) in patients receiving primary RT (± chemotherapy) for locally advanced head and neck cancer (HNC). Material and methods: Twenty-seven locally advanced HNC patients who have no finDing of brachial plexopathy at the diagnosis were evaluated 3 times by a specifically developed 13-item questionnaire for determining early transient RIBP. The 54 brachial plexus in 27 patients were delineated and dose volume histograms were calculated. Results: Median follow-up period was 28 (range: 15-40) months. The mean BP volume was 7.9 ±3.6 cm3, and the mean and maximum doses to the BP were 45.3 (range: 32.3-59.3) Gy, and 59.4 (range: 41.4-70.3) Gy, respectively. Maximum dose to the BP was 70 Gy only in 2 nasopharyngeal cancer patients. Two (7%) early transient RIBP were reported at 7th and 8th month after RT under maximum 67.17 and 55.37 Gy, and mean 52.95 and 38.60 Gy RT doses. Conclusions: Two (7%) early RIBP were seen in the patient group, although brachial plexus maximum doses were 66 Gy in 75% of patients.